Novel Radiopharmaceutical Beats Cabazitaxel in mCRPC
A novel radiopharmaceutical was more active than cabazitaxel against metastatic castration-resistant prostate cancer (mCRPC) and caused fewer grade 3/4 adverse …
Home ยป
Metal-containing radiopharmaceuticals could improve access to diagnostic imaging of AD
A team of researchers from the Laboratory of Biophysics at NUST MISIS, Lomonosov Moscow State University and D. Mendeleev University …